Our results are consistent with previous studies showing that inhibition of purine synthesis in tumor cells mainly suppresses mTORC1/S6K/S6 signaling (Emmanuel et al., 2017; Hoxhaj et al., 2017). The gene discussed is RPS6KB1; the disease is neoplasm.